Eyes and ears and nose, percutaneous approach

85812100 Level 3 · Class Category

38 items in this category

  • 85812116Introduction of analgesics, hypnotics, sedatives into ear, percutaneous approach
    Exempt
  • 85812103Introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach
    Exempt
  • 85812128Introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach
    Exempt
  • 85812121Introduction of anti-inflammatory into ear, percutaneous approach
    Exempt
  • 85812109Introduction of anti-inflammatory into eye, percutaneous approach
    Exempt
  • 85812134Introduction of anti-inflammatory into nose, percutaneous approach
    Exempt
  • 85812115Introduction of destructive agent into ear, percutaneous approach
    Exempt
  • 85812101Introduction of destructive agent into eye, percutaneous approach
    Exempt
  • 85812127Introduction of destructive agent into nose, percutaneous approach
    Exempt
  • 85812126Introduction of liquid brachytherapy radioisotope into ear, percutaneous approach
    Exempt
  • 85812114Introduction of liquid brachytherapy radioisotope into eye, percutaneous approach
    Exempt
  • 85812120Introduction of local anesthetic into ear, percutaneous approach
    Exempt
  • 85812108Introduction of local anesthetic into eye, percutaneous approach
    Exempt
  • 85812132Introduction of local anesthetic into nose, percutaneous approach
    Exempt
  • 85812124Introduction of monoclonal antibody into ear, percutaneous approach
    Exempt
  • 85812112Introduction of monoclonal antibody into eye, percutaneous approach
    Exempt
  • 85812137Introduction of monoclonal antibody into nose, percutaneous approach
    Exempt
  • 85812122Introduction of other anti-infective into ear, percutaneous approach
    Exempt
  • 85812110Introduction of other anti-infective into eye, percutaneous approach
    Exempt
  • 85812135Introduction of other anti-infective into nose, percutaneous approach
    Exempt
  • 85812125Introduction of other antineoplastic into ear, percutaneous approach
    Exempt
  • 85812113Introduction of other antineoplastic into eye, percutaneous approach
    Exempt
  • 85812138Introduction of other antineoplastic into nose, percutaneous approach
    Exempt
  • 85812117Introduction of other diagnostic substance into ear, percutaneous approach
    Exempt
  • 85812105Introduction of other diagnostic substance into eye, percutaneous approach
    Exempt
  • 85812129Introduction of other diagnostic substance into nose, percutaneous approach
    Exempt
  • 85812102Introduction of other gas into eye, percutaneous approach
    Exempt
  • 85812119Introduction of other therapeutic substance into ear, percutaneous approach
    Exempt
  • 85812107Introduction of other therapeutic substance into eye, percutaneous approach
    Exempt
  • 85812131Introduction of other therapeutic substance into nose, percutaneous approach
    Exempt
  • 85812123Introduction of oxazolidinones into ear, percutaneous approach
    Exempt
  • 85812111Introduction of oxazolidinones into eye, percutaneous approach
    Exempt
  • 85812136Introduction of oxazolidinones into nose, percutaneous approach
    Exempt
  • 85812104Introduction of pigment into eye, percutaneous approach
    Exempt
  • 85812118Introduction of radioactive substance into ear, percutaneous approach
    Exempt
  • 85812106Introduction of radioactive substance into eye, percutaneous approach
    Exempt
  • 85812130Introduction of radioactive substance into nose, percutaneous approach
    Exempt
  • 85812133Introduction of serum, toxoid and vaccine into nose, percutaneous approach
    Exempt
← Back to search